Perspectiva global sobre los datos de tratamientos emergentes con inhibidores de TQB para LLC y LCM en recidiva/refractarios en 2022

Content Format:

Text Module

Credit Type:

--

Credits:

--
Une perspective globale sur les données émergentes relatives à la thérapie par inhibiteurs BTK chez les patients atteints de LLC ou du LCM récidivant/réfractaire en 2022

Content Format:

Text Module

Credit Type:

--

Credits:

--
A Global Perspective on Emerging BTK Inhibitor Therapy Data for Relapsed/Refractory CLL and MCL in 2022

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.00
Nos réflexions sur les implications des nouvelles données concernant la LLC et le LCM après l’ASCO 2022

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Unsere Überlegungen zu den Auswirkungen der neuen Daten zu CLL und MCL von der Jahrestagung der ASCO 2022

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Le nostre considerazioni riguardo alle implicazioni dei nuovi dati su LLC e MCL emersi dallASCO 2022

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Nossas reflexões sobre as Implicações dos novos dados em LLC e LCM da ASCO 2022

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Reflexiones sobre las novedades sobre LLC y LCM presentadas en ASCO 2022

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
New Evidence With BTK Inhibitor Therapy in CLL and MCL From ASCO 2022

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Our Thoughts on the Implications of New Data in CLL and MCL From ASCO 2022

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
How I’m Adapting My Frontline DLBCL Approaches Based on Recent Advances

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Advances in B-Cell Lymphomas: Understanding Current Treatment Approaches

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Podcast Pearls: Advances Across B Cell Lymphomas

Content Format:

PDF

Credit Type:

--

Credits:

--
A Class in Session: Understanding Current and Future Therapeutic Advances Across B-Cell Lymphomas

Content Format:

Multimedia

Credit Type:

AMA

Credits:

2.25
ExpressPoints: Understanding Current and Future Therapeutic Advances Across B-Cell Lymphomas

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
What’s New in Marginal Zone Lymphoma and Mantle Cell Lymphoma?

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
How I Treat Patients With Mantle Cell Lymphoma

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--